A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation.

BACKGROUND Exhaled nitric oxide (ENO) has been proposed as a noninvasive marker of airway inflammation in asthma. OBJECTIVE We investigated the relationships among ENO, eosinophilic airway inflammation as measured by induced sputum, and physiologic parameters of disease severity (spirometry and methacholine PC(20)). We also examined the effect of corticosteroid treatment and atopy on ENO levels and eosinophil counts in induced sputum. METHODS Measurements were taken on one day in 22 healthy nonatopic subjects, 28 healthy atopic subjects, 38 asthmatic subjects not taking inhaled steroids, 35 asthmatic subjects taking inhaled steroids, and 8 subjects with eosinophilic bronchitis without asthma. RESULTS ENO levels showed significant but weak correlations with eosinophil differential counts in the steroid-naive asthmatic and healthy atopic groups (r (s) < 0.05). ENO levels were significantly lower in the asthmatic subjects taking steroids compared with the asthmatic subjects not taking steroids, despite there being no difference in the sputum cell counts, and a tendency to increased airflow limitation. ENO levels and sputum eosinophil counts were equally good at differentiating from steroid-naive asthmatic subjects. ENO levels were consistently raised in subjects with eosinophilic bronchitis without asthma. Atopy had no effect on ENO levels in the healthy subjects. CONCLUSION We conclude that ENO is likely to have limited utility as a surrogate clinical measurement for either the presence or severity of eosinophilic airway inflammation, except in steroid-naive subjects.

[1]  P. O'Byrne,et al.  Induced sputum cell counts in healthy adults. , 2000, American journal of respiratory and critical care medicine.

[2]  I. Pavord,et al.  Non-eosinophilic cor ticosteroid unresponsive asthma , 1999, The Lancet.

[3]  A. Zwinderman,et al.  Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma , 1999, Thorax.

[4]  P. Barnes,et al.  Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma , 1999, Thorax.

[5]  K. Chung,et al.  Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. , 1999, American journal of respiratory and critical care medicine.

[6]  S. Durham,et al.  Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids , 1998, Thorax.

[7]  F. Hargreave,et al.  Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. , 1998, American journal of respiratory and critical care medicine.

[8]  I. Horváth,et al.  Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. , 1998, American journal of respiratory and critical care medicine.

[9]  P. Barnes,et al.  Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  F. Hargreave,et al.  Serial sputum cell counts in the management of chronic airflow limitation. , 1998, The European respiratory journal.

[11]  Arthur S Slutsky,et al.  Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. , 1998, American journal of respiratory and critical care medicine.

[12]  P. Barnes,et al.  Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5′-monophosphate in asthma , 1998, Thorax.

[13]  G. Verleden,et al.  Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. , 1998, American journal of respiratory and critical care medicine.

[14]  K. Chung,et al.  Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. , 1998, Thorax.

[15]  Arthur S Slutsky,et al.  Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.

[16]  P. Barnes,et al.  Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. , 1997, The European respiratory journal.

[17]  F. Hargreave,et al.  Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. , 1997, American journal of respiratory and critical care medicine.

[18]  Arthur S Slutsky,et al.  Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. , 1997, American journal of respiratory and critical care medicine.

[19]  M. Jordana,et al.  Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. , 1996, American journal of respiratory and critical care medicine.

[20]  Todor A Popov,et al.  Spontaneous and induced sputum to measure indices of airway inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[21]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[22]  P. Barnes,et al.  Exhaled nitric oxide: a new lung function test. , 1996, Thorax.

[23]  D. Yates,et al.  Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. , 1996, The European respiratory journal.

[24]  D. Yates,et al.  Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. , 1996, American journal of respiratory and critical care medicine.

[25]  L. Fabbri,et al.  Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.

[26]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[27]  D M Hansell,et al.  Elevated levels of exhaled nitric oxide in bronchiectasis. , 1995, American journal of respiratory and critical care medicine.

[28]  D. Yates,et al.  Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. , 1995, The European respiratory journal.

[29]  P. Holzer,et al.  Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. , 1994, The European respiratory journal.

[30]  G. Guyatt,et al.  A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[31]  J. Denburg,et al.  Use of induced sputum cell counts to investigate airway inflammation in asthma. , 1992, Thorax.

[32]  J. Denburg,et al.  CHRONIC COUGH: EOSINOPHILIC BRONCHITIS WITHOUT ASTHMA , 1989, The Lancet.

[33]  J. Gerrard,et al.  Letter: Sex-linked mental retardation. , 1974, Lancet.

[34]  P. Gell,et al.  Clinical aspects of immunology , 1968 .